To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Eva Marie Uzcategui / Bloomberg / Getty Images CVS Health reported better-than-expected quarterly results, and the new CEO ...

J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers the ...

CVS Health Corp. faces continued challenges in its insurance business, prompting the company to shake up its management ranks in a bid to get back on track. Shares of the pharmacy and healthcare ...

CVS Health (CVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz ...

CVS expects elevated medical costs to continue to pressure its performance this year, “and as a result we are not providing a ...

Here is a list of many popular retailers that are confirmed to be open on Veterans Day 2024, along with their store hours, ...

CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...

In the Commercial vehicles (CVs), the report noted that it showed a more subdued performance, with overall sales remaining largely flat on a YoY basis but experiencing a 9 per cent MoM increase.

U.S. equities were mixed at midday with the tech sector getting a big boost from Netflix, which reported strong quarterly ...

CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant ... will lead CVS Caremark, CVS Pharmacy, and the company’s Health Care Delivery businesses.